Completed

Promoting Self -Care to Prevent Urinary Incontinence

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Bladder Health Class

Behavioral
Who is being recruted

Urogenital Diseases+10

+ Mental Disorders

+ Behavioral Symptoms

From 55 to 80 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 3
Interventional
Study Start: September 2000
See protocol details

Summary

Principal SponsorUniversity of Michigan
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: September 1, 2000

Actual date on which the first participant was enrolled.

This is a study that will monitor and compare attitudes and strategies that women use to maintain behavior changes that prevent urination problems. Women will complete questionnaires, do muscle strength exercises, and bladder training at 3 months, one year, and 4 years post intervention.

Official TitlePromoting Self -Care to Prevent Urinary Incontinence 
Principal SponsorUniversity of Michigan
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

417 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

From 55 to 80 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesMental DisordersBehavioral SymptomsEnuresisFemale Urogenital Diseases and Pregnancy ComplicationsUrinary IncontinenceUrination DisordersUrologic DiseasesElimination DisordersUrological ManifestationsFemale Urogenital DiseasesMale Urogenital DiseasesLower Urinary Tract Symptoms

Criteria

Inclusion and exclusion criteria 1. Female 55 through 80 years old 2. Post-menopausal-no menstrual cycle for the past 12 months except for women who are on hormone replacement therapy. 3. Continent of urine (using the MESA definition of continence) defined as: 1. No previous incontinence episode except during pregnancy and/or postpartum period. 2. Urine loss less than 6 days during the last 365 days 3. No previous or present incontinence treatment with pharmacological agents, behavioral programs or surgical therapy. 4. No history of bladder cancer, stroke, multiple sclerosis, parkinsonism, epilepsy, spinal cord tumor or trauma. 5. No reported difficulty with activities of daily living, i.e. walking about the house, dressing, getting in/out of bed, getting to/using the toilet, bathing/showering, or eating. Additional criteria are applied at a physical examination: 1. Mini Mental Status of at least 24 2. Negative for objective urine loss during coughing.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

A two-hour bladder health class presented by two experts in urinary incontinence and followed by an individual follow-up teaching session with an incontinence nurse specialist.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

University of Michigan

Ann Arbor, United StatesSee the location
CompletedOne Study Center